High expressions of tumor cell genes COL5A2 and ITGAV and non-tumor cell genes SPARC and ACTA2 are both positively correlated with poor overall survival and disease-free survival in MESO cohort (Fig. 5). Here, COL5A2 is linked to neoplasm.